Raji Cells
Raji cells are a type of B lymphocyte cell line that have been widely studied in hematology and oncology research. They were first isolated from a Burkitt's lymphoma patient and have since become a valuable tool for studying B cell development, differentiation, and immunotherapy. Raji cells are used as a model system for the study of EBV-associated B cell lymphomas and other hematological disorders. They have been instrumental in developing new drugs and therapies for these diseases, as well as in understanding the biology of B cell cancers. In addition to their use in research, Raji cells are also used in diagnostic tests such as the Epstein-Barr virus (EBV) antibody assay. This test measures the presence of antibodies against the EBV virus in the blood, which can be indicative of viral infection or the development of lymphoma. Raji cells are characterized by their ability to grow in vitro and their similarity to primary B cells in terms of gene expression and response to stimuli. They are widely used for testing the efficacy and toxicity of new drugs in preclinical studies, as well as for studying the molecular mechanisms underlying lymphomagenesis. In summary, Raji cells are a critical tool in both basic and clinical hematology and oncology research. They provide a valuable model system for studying B cell lymphomas and related diseases, as well as for developing new diagnostic and therapeutic strategies. By understanding the biology of these cell lines, researchers can improve the treatment and outcomes for patients with these diseases.
← Hematology Research and Oncology Research